Pharmaceutical utilisation and costs before and after bariatric surgery

被引:0
作者
C L Keating
A Peeters
B A Swinburn
R Carter
M L Moodie
机构
[1] Deakin Health Economics,
[2] Deakin University,undefined
[3] Obesity and Population Health,undefined
[4] Baker IDI Heart and Diabetes Institute,undefined
[5] World Health Organisation Collaborating Centre for Obesity Prevention,undefined
[6] Deakin University,undefined
来源
International Journal of Obesity | 2013年 / 37卷
关键词
cost; economic; healthcare; pharmaceutical; bariatric surgery; gastric banding;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1467 / 1472
页数:5
相关论文
共 271 条
[1]  
Walls HL(2010)Trends in BMI of urban Australian adults, 1980-2000 Public Health Nutr 13 631-638
[2]  
Wolfe R(2002)Trends and correlates of class 3 obesity in the United States from 1990 through 2000 JAMA 288 1758-1761
[3]  
Haby MM(2008)Shift in the composition of obesity in young adult men in Sweden over a third of a century Int J Obes 32 832-836
[4]  
Magliano DJ(2006)Extreme obesity: a new medical crisis in the United States Mayo Clin Proc 81 S5-10
[5]  
de Courten M(1999)The disease burden associated with overweight and obesity JAMA 282 1523-1529
[6]  
Reid CM(1995)Weight gain as a risk factor for clinical diabetes mellitus in women Ann Intern Med 122 481-486
[7]  
Freedman DS(1994)Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men Diabetes Care 17 961-969
[8]  
Khan LK(1997)The treatment and prevention of obesity: a systematic review of the literature Int J Obes Relat Metab Disord 21 715-737
[9]  
Serdula MK(2005)Meta-analysis: surgical treatment of obesity Ann Intern Med. 142 547-559
[10]  
Galuska DA(2005)Obesity, weight loss and bariatric surgery Med J Aust 183 310-314